Advertisement

Search Results

Advertisement



Your search for Dario C. Altieri, MD,Dario C. Altieri, MD matches 3 pages

Showing 1 - 3


Wall Street Doesn’t Believe in This Target

March 2, 2009. Just published in the Journal of Clinical Investigation.1 And we even got the cover. Twists and turns of heat shock protein-90 (Hsp90), the chaperone, the evolutionary capacitor. Great name and important cancer target. People smiled when I talked about this at the Hsp90 conference....

issues in oncology

Creating Hybrid Academic-Community Cancer Centers to Improve Patient Care

Five years ago, the Helen F. Graham Cancer Center and Research Institute at Christiana Care Health System in Newark, Delaware, and The Wistar Institute, a National Cancer Institute (NCI)-designated biomedical research center, in Philadelphia, Pennsylvania, joined forces to collaborate on...

issues in oncology
issues in oncology

Treatment With PI3K Inhibitors May Cause Cancers to Become More Aggressive and Metastatic

The enzyme phosphatidylinositol-3 kinase (PI3K) appears to be exploited in almost every type of human cancer, making it the focus of considerable interest as a therapeutic target, with many PI3K-inhibiting drugs currently in various stages of clinical development. However, PI3K inhibitors have only ...

Advertisement

Advertisement



Advertisement